APA (7th ed.) Citation

Wang, L., Da, H., Li, X., Ran, X., Wu, W., & Sheng, Z. (2020). Comparison of CD4/6 inhibitors, PI3K inhibitors, and mTOR inhibitors for patients with advanced HR+/HER2‐ Breast cancer: A network meta‐analysis of 19 RCTs. Breast Journal, 26(9), 1862. https://doi.org/10.1111/tbj.13780

Chicago Style (17th ed.) Citation

Wang, Lida, Huo Da, Xiulian Li, Xuehong Ran, Wei Wu, and Zhixin Sheng. "Comparison of CD4/6 Inhibitors, PI3K Inhibitors, and MTOR Inhibitors for Patients with Advanced HR+/HER2‐ Breast Cancer: A Network Meta‐analysis of 19 RCTs." Breast Journal 26, no. 9 (2020): 1862. https://doi.org/10.1111/tbj.13780.

MLA (9th ed.) Citation

Wang, Lida, et al. "Comparison of CD4/6 Inhibitors, PI3K Inhibitors, and MTOR Inhibitors for Patients with Advanced HR+/HER2‐ Breast Cancer: A Network Meta‐analysis of 19 RCTs." Breast Journal, vol. 26, no. 9, 2020, p. 1862, https://doi.org/10.1111/tbj.13780.